Standout Papers

Current concepts in the diagnosis and management of cytok... 2006 2026 2012 2019 1.9k
  1. Current concepts in the diagnosis and management of cytokine release syndrome (2014)
    Daniel W. Lee, Rebecca Gardner et al. Blood
  2. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (2006)
    Andrew T. Parsa, James S. Waldron et al. Nature Medicine
  3. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults (2017)
    Rebecca Gardner, Olivia Finney et al. Blood
  4. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates (2008)
    Carolina Berger, Michael C. Jensen et al. Journal of Clinical Investigation
  5. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma (2015)
    Christine E. Brown, Behnam Badie et al. Clinical Cancer Research
  6. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells (2008)
    Brian G. Till, Michael C. Jensen et al. Blood
  7. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy (2016)
    Rebecca Gardner, David Wu et al. Blood
  8. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells (2011)
    Xiuli Wang, Wen-Chung Chang et al. Blood
  9. T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells (2016)
    Eugenia Zah, Meng-Yin Lin et al. Cancer Immunology Research
  10. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results (2012)
    Brian G. Till, Michael C. Jensen et al. Blood

Immediate Impact

12 by Nobel laureates 47 from Science/Nature 361 standout
Sub-graph 1 of 13

Citing Papers

De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
5 intermediate papers

Works of Michael C. Jensen being referenced

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
2015 Standout
In Vivo Testing of Renilla Luciferase Substrate Analogs in an Orthotopic Murine Model of Human Glioblastoma
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael C. Jensen 15068 6602 5094 248 19.8k
Renier J. Brentjens 14711 6602 5037 194 17.7k
David L. Porter 15738 6177 4727 205 18.9k
Michael Kalos 11484 5916 4825 94 15.2k
Marcela V. Maus 9657 4734 4801 199 13.3k
Isabelle Rivière 8876 4211 4079 156 11.8k
Bruce L. Levine 22282 13718 9047 253 31.9k
Stephan A. Grupp 20863 8804 7996 322 28.5k
Stephen Gottschalk 9130 4584 2938 252 11.8k
James C. Yang 14905 11845 5634 135 20.4k
Laurence J.N. Cooper 7481 4616 4194 230 11.1k

All Works

Loading papers...

Rankless by CCL
2026